Wanbo Tai

5.0k total citations · 2 hit papers
45 papers, 3.1k citations indexed

About

Wanbo Tai is a scholar working on Infectious Diseases, Animal Science and Zoology and Molecular Biology. According to data from OpenAlex, Wanbo Tai has authored 45 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Infectious Diseases, 15 papers in Animal Science and Zoology and 11 papers in Molecular Biology. Recurrent topics in Wanbo Tai's work include SARS-CoV-2 and COVID-19 Research (23 papers), Animal Virus Infections Studies (15 papers) and Viral gastroenteritis research and epidemiology (13 papers). Wanbo Tai is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (23 papers), Animal Virus Infections Studies (15 papers) and Viral gastroenteritis research and epidemiology (13 papers). Wanbo Tai collaborates with scholars based in United States, China and Singapore. Wanbo Tai's co-authors include Lanying Du, Yusen Zhou, Shibo Jiang, Lei He, Xiujuan Zhang, Denis Voronin, Jing Pu, Shihui Sun, Guangyu Zhao and Jian Shang and has published in prestigious journals such as Nature Communications, Nature Materials and SHILAP Revista de lepidopterología.

In The Last Decade

Wanbo Tai

44 papers receiving 3.0k citations

Hit Papers

Characterization of the receptor-binding domain (RBD) of ... 2019 2026 2021 2023 2020 2019 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wanbo Tai United States 23 2.4k 721 512 404 341 45 3.1k
Rita E. Chen United States 20 2.3k 0.9× 802 1.1× 314 0.6× 393 1.0× 317 0.9× 27 2.9k
Michael Letko United States 17 2.6k 1.1× 534 0.7× 412 0.8× 279 0.7× 402 1.2× 33 3.3k
James Brett Case United States 23 2.2k 0.9× 736 1.0× 288 0.6× 337 0.8× 309 0.9× 35 3.0k
Alessandro M. Carabelli United Kingdom 9 2.7k 1.1× 939 1.3× 359 0.7× 277 0.7× 215 0.6× 11 3.1k
Susanne Pfefferle Germany 24 2.4k 1.0× 492 0.7× 537 1.0× 267 0.7× 392 1.1× 63 3.2k
Emma C. Thomson United Kingdom 22 2.9k 1.2× 938 1.3× 326 0.6× 284 0.7× 828 2.4× 90 4.0k
Weijin Huang China 30 3.4k 1.4× 1.1k 1.5× 477 0.9× 425 1.1× 737 2.2× 186 4.8k
Wan Ni Chia Singapore 19 3.1k 1.3× 861 1.2× 309 0.6× 649 1.6× 299 0.9× 43 4.1k
Lili Wu China 13 2.0k 0.8× 697 1.0× 324 0.6× 222 0.5× 291 0.9× 29 2.6k

Countries citing papers authored by Wanbo Tai

Since Specialization
Citations

This map shows the geographic impact of Wanbo Tai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanbo Tai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanbo Tai more than expected).

Fields of papers citing papers by Wanbo Tai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wanbo Tai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanbo Tai. The network helps show where Wanbo Tai may publish in the future.

Co-authorship network of co-authors of Wanbo Tai

This figure shows the co-authorship network connecting the top 25 collaborators of Wanbo Tai. A scholar is included among the top collaborators of Wanbo Tai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wanbo Tai. Wanbo Tai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tai, Wanbo, Xinyang Yu, Xinyu Zhuang, et al.. (2025). An mRNA vaccine against monkeypox virus inhibits infection by co-activation of humoral and cellular immune responses. Nature Communications. 16(1). 2971–2971. 8 indexed citations
2.
Zhang, Yuhang, Xinyang Yu, Guocan Yu, et al.. (2024). Lung-Selective Delivery of mRNA-Encoding Anti-MERS-CoV Nanobody Exhibits Neutralizing Activity Both In Vitro and In Vivo. Vaccines. 12(12). 1315–1315. 2 indexed citations
3.
Yang, Shuo, Meijie Tian, Rong Wang, et al.. (2024). Infection and chronic disease activate a systemic brain-muscle signaling axis. Science Immunology. 9(97). eadm7908–eadm7908. 9 indexed citations
4.
Shi, Juan, Jian Zheng, Xiujuan Zhang, et al.. (2024). A T cell–based SARS-CoV-2 spike protein vaccine provides protection without antibodies. JCI Insight. 9(5). 7 indexed citations
5.
Tai, Wanbo, Tao Wang, Shuyue Guo, et al.. (2024). Inhalable nanocatalytic therapeutics for viral pneumonia. Nature Materials. 24(4). 637–648. 23 indexed citations
7.
Meng, Qian‐Fang, Wanbo Tai, Mingyao Tian, et al.. (2023). Inhalation delivery of dexamethasone with iSEND nanoparticles attenuates the COVID-19 cytokine storm in mice and nonhuman primates. Science Advances. 9(24). eadg3277–eadg3277. 76 indexed citations
8.
Tai, Wanbo, Shuaiyao Lu, Guangyu Zhao, et al.. (2023). An mRNA-based T-cell-inducing antigen strengthens COVID-19 vaccine against SARS-CoV-2 variants. Nature Communications. 14(1). 2962–2962. 35 indexed citations
9.
Tai, Wanbo, Jian Zheng, Xiujuan Zhang, et al.. (2023). MERS-CoV RBD-mRNA vaccine induces potent and broadly neutralizing antibodies with protection against MERS-CoV infection. Virus Research. 334. 199156–199156. 10 indexed citations
10.
Shi, Juan, Jian Zheng, Wanbo Tai, et al.. (2022). A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection. Journal of Virology. 96(17). e0011822–e0011822. 19 indexed citations
11.
Tai, Wanbo, Xinyi Wang, Shibo Jiang, et al.. (2022). A gossypol derivative effectively protects against Zika and dengue virus infection without toxicity. BMC Biology. 20(1). 143–143. 10 indexed citations
12.
Huang, He, Yingying Fang, Gang Liu, et al.. (2022). Re-burying Artificially Exposed Surface of Viral Subunit Vaccines Through Oligomerization Enhances Vaccine Efficacy. Frontiers in Cellular and Infection Microbiology. 12. 927674–927674. 1 indexed citations
13.
Shi, Juan, Jian Zheng, Xiujuan Zhang, et al.. (2022). RBD-mRNA vaccine induces broadly neutralizing antibodies against Omicron and multiple other variants and protects mice from SARS-CoV-2 challenge. Translational research. 248. 11–21. 15 indexed citations
14.
Cao, Wenpeng, Seonghan Kim, Wanbo Tai, et al.. (2021). Biomechanical characterization of SARS-CoV-2 spike RBD and human ACE2 protein-protein interaction. Biophysical Journal. 120(6). 1011–1019. 89 indexed citations
15.
Ye, Gang, Jian Zheng, Ke Shi, et al.. (2021). The development of Nanosota-1 as anti-SARS-CoV-2 nanobody drug candidates. eLife. 10. 40 indexed citations
16.
Tai, Wanbo, Denis Voronin, Yi Zhang, et al.. (2021). A vaccine inducing solely cytotoxic T lymphocytes fully prevents Zika virus infection and fetal damage. Cell Reports. 35(6). 109107–109107. 22 indexed citations
17.
Wan, Yushun, Jian Shang, Shihui Sun, et al.. (2019). Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry. Journal of Virology. 94(5). 462 indexed citations breakdown →
18.
Tai, Wanbo, Denis Voronin, Weili Bao, et al.. (2019). Transfusion-Transmitted Zika Virus Infection in Pregnant Mice Leads to Broad Tissue Tropism With Severe Placental Damage and Fetal Demise. Frontiers in Microbiology. 10. 29–29. 11 indexed citations
20.
Du, Lanying, Wanbo Tai, Yusen Zhou, & Shibo Jiang. (2016). Vaccines for the prevention against the threat of MERS-CoV. Expert Review of Vaccines. 15(9). 1123–1134. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026